Effect of Super-Oxygenated Water on Blood Oxygen Saturation
A Randomized, Double-blinded and Placebo-controlled Study on Super-Oxygenated Water
1 other identifier
interventional
60
1 country
1
Brief Summary
Therapeutic delivery of additional Oxygen to blood stream via hyperbaric and extracorporeal oxygenation that raises blood Oxygen saturation level, apart from oxygenation in the lungs, is known to induce tissue repair, restore normal body functions and improve survival. Despite the clinical benefits obtained from these interventions, Oxygen supplementation is rather a medically involved process requiring access to specialized equipment including hyperbaric chambers, cardiac catheterization laboratory and extracorporeal oxygenators, and is not generally amenable for everyday use. The current prospective study will evaluate a non-invasive route for Oxygen delivery through ingestion of super-oxygenated water in adult volunteers. The participants will be randomly assigned to one of the two study groups viz. Inhale super-oxygenated water or placebo control normal water at 1:1 ratio. Neither the participants nor the study doctor will know the treatment assignment. Pre- and post-ingestion measurements will be conducted to evaluate effect of super-oxygenated water.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 16, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2025
CompletedResults Posted
Study results publicly available
January 27, 2026
CompletedJanuary 27, 2026
January 1, 2026
7 months
May 16, 2025
December 2, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
SpO2 Response Rate
Number of participants who experienced an improvement in post-ingestion SpO2. An increase in post-ingestion SpO2 over the pre-ingestion level in the same subject was considered a response.
From pre-ingestion to post-ingestion of water
Heart Rate Response Rate
Number of participants who experienced a reduction in post-ingestion heart rate. A decrease in post-ingestion heart rate over the pre-ingestion level in the same subject was considered a response.
From pre-ingestion to post-ingestion of water
Secondary Outcomes (2)
Energy Level Response Rate
From pre-ingestion to post-ingestion of water
Brain Clarity Response Rate
From pre-ingestion to post-ingestion of water
Study Arms (2)
Inhale Water
EXPERIMENTALParticipants will ingest 12oz of Inhale Super-Oxygenated water
Normal Water
PLACEBO COMPARATORParticipants will ingest 12oz of Source and Taste-matched normal water
Interventions
Eligibility Criteria
You may qualify if:
- Legally adult (18 years of age or older)
- Subject must be willing to review and provide a written informed consent
- Subject must agree to the study procedures including water ingestion, and SPO2 and heart rate measurements
You may not qualify if:
- Any active and life-threatening medical condition involving hepatic, renal, cardiac, respiratory, endocrine, or gastrointestinal systems, or any blood disorder in view of the Principal Investigator to confound the study
- Female subjects those are pregnant, nursing or planning to become pregnant
- Subjects receiving any experimental medications or have undergone a major surgical procedure in last 30 days
- Subjects are excluded if they have previously utilized the test article (INHALE superoxygenated water) within the last 24 hours, or have undergone bariatric surgery or have received weight-loss medication
- Subjects with known anemia, hemoglobinopathy or other comorbidity necessitating fluid restriction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inhale, Inclead
Study Sites (1)
The Center For Whole Health
Westlake Village, California, 91362, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ian Mitchell
- Organization
- Inhale Inc
Study Officials
- STUDY DIRECTOR
Deepak Nayak, PhD
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2025
First Posted
June 11, 2025
Study Start
May 1, 2025
Primary Completion
November 26, 2025
Study Completion
November 28, 2025
Last Updated
January 27, 2026
Results First Posted
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The results will be utilized in business decisions and possible publications. At this point the data may or may not be shared.